Physician Photo

Jeffrey A. Barnes, MD, PhD

Jeffrey Barnes, MD, PhD, is a medical oncologist at the Massachusetts General Hospital Cancer Center's Comprehensive Cutaneous Lymphoma Program and Center for Lymphoma.

  • Phone: 617-724-4000
Departments
Hematology/Oncology
Department of Medicine

Specialties

  • Cancer Center
  • Non-Hodgkin Lymphoma
  • Lymphoma
  • Hodgkin Lymphoma
Clinical Interests
Chronic lymphocytic leukemia (CLL)
Cutaneous b-cell lymphoma
Cutaneous t-cell lymphoma
Hodgkin's lymphoma (also known as Hodgkin's disease)
Non-Hodgkin's lymphoma (NHL)
Medical Education
MD, PhD, University of Illinois College of Medicine
Residency, Beth Israel Deaconess Medical Center
Fellowship, Dana Farber Cancer Institute
Board Certifications
Internal Medicine, American Board of Internal Medicine
Hematology, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Gender
Male
Patient Age Group
Adult
Accepting New Patients
Yes

BiographyJeffrey Barnes, MD, PhD is a graduate of the University of Illnois College of Medicine. He completed his residency in Internal Medicine at the Beth Israel Deaconess Medical Center in Boston. He then completed his fellowship in Medical Oncology at the Dana Farber Cancer Institute before joining the faculty at the Massachusetts General Hospital. He is a member of the US Cutaneous Lymphoma Consortium. His research interests focus on the identification and evaluation of novel agents for the treatment of lymphoma.

ResearchDr.Barnes performs translational research in lymphoma including clinical trials of novel therapies for the treatment of cutaneous lymphoma, non-Hodgkin lymphomas, Hodgkin lymphoma (Hodgkin's disease), and chronic lymphocytic leukemia.

Publications

Barnes JA, Abramson JS. Differential Diagnosis and Novel Treatment Strategies for Adult T Cell Leukemia Lymphoma. Oncology. Dec 23;14, p.1267-1270 (2009)

Abramson JS, Hellmann M, Barnes JA, Hammermann P, Toomey C, Takvorian T, Muzikansky A, Hochberg EP. Intravenous methotrexate as central nervous system prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer Jun 8 Epub ahead of print (2010)

Barnes JA, LaCasce AS, Zukotynski K, Israel D, Feng Y, Neuburg D, Tomey C, Hochberg EP, Canellos GP, Abramson JS. End of treatment but not interim PET scan predicts outcomes in non-bulky limited stage Hodgkin lymphoma. Ann of Oncology  Oct 15 (2010)

Barnes JA, LaCasce AS, Feng Y, Tomey C, Neuburg D, Michaelson JS, Hochberg EP, Abramson JS. Evaluation of the Addition of Rituximab to CODOX-M/IVAC for Burkitt Lymphoma: A Retrospective Analysis. Ann of Oncology In Feb 21 (2011)

Hematology/Oncology
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-724-4000
Fax: 617-724-6801

Martha's Vineyard Hospital
One Hospital Road
Oak Bluffs, MA 02557

Phone: 508-957-0119

Nantucket Cottage Hospital
57 Prospect Street
Nantucket, MA 02554

Phone: 508-825-8165
Fax: 508-825-8172